Podcast Episodes

The future of gene therapy

Today, gene therapy is at an exciting inflection point as the industry moves beyond the first generation of these therapies. However, challenges and …

2 years ago

Bispecific ADCs: the next generation of cancer treatments

Antibody-drug conjugates have been an area of great interest in the oncology space in recent years, with a record rate of FDA approvals and dealmakin…

2 years ago

Targeting telomerase to disrupt cancer

Telomeres are structures made from DNA sequences and proteins, and they are found at the ends of chromosomes.

In effect, they cap and protect the end…

2 years ago

Harnessing the body’s natural targeted protein degradation system to treat diseases

C4 Therapeutics (C4T) is a leader in the targeted protein degradation (TPD) field, with two oncology drug candidates currently in clinical trials and…

2 years ago

Estonia's biobank: Is this the first large-scale personalized medicine initiative?

Estonia is working on becoming the first country to implement personalized health at scale through the Estonian National Biobank.

The biobank uses gen…

2 years ago

Targeting inflammation: A revolution in disease treatment

Inflammation appears to affect almost every part of the human body as we age, including cancer, type-2 diabetes, obesity, and neurodegenerative disor…

2 years, 1 month ago

The power of tumor infiltrating lymphocytes to fight melanoma

Tumor infiltrating lymphocyte (TIL) therapy uses a person’s own immune cells to fight advanced melanoma, offering new hope for patients who have limi…

2 years, 1 month ago

The future of combination vaccines

The development of combination vaccines could represent a significant advancement in the fight against infectious diseases. With the potential to str…

2 years, 1 month ago

New German biotech spins out to develop radiotherapeutics

Pentixapharm is a clinical-stage radiopharmaceutical development company targeting a range of diseases. 

While it is currently owned by the Eckert & Z…

2 years, 1 month ago

Challenging the European biotech funding status quo

There are many questions when it comes to setting up a biotech company, and raising funds.

Currently, many companies are concerned about fundraising,…

2 years, 2 months ago